PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Clinical trials for PERIPHERAL ARTERIAL OCCLUSIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL ARTERIAL OCCLUSIVE DISEASE trials appear
Sign up with your email to follow new studies for PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MS drug trial aims to help PAD patients walk farther
Disease control Recruiting nowThis early-stage study is testing if a single dose of an existing drug, diroximel fumarate (Vumerity), can help people with peripheral artery disease (PAD) walk better. Researchers believe the drug may reduce harmful stress in blood vessels, improving blood flow to the legs. Abou…
Matched conditions: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Phase: EARLY_PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New balloon treatment aims to save limbs from amputation
Disease control Recruiting nowThis study is collecting real-world data on a specific drug-coated balloon used to treat blocked leg arteries (peripheral arterial disease). It will follow about 284 patients in Europe for three years after their procedure to see how safe the treatment is and how well it works at…
Matched conditions: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Sponsor: OrbusNeich • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New drug aims to save limbs from amputation
Disease control Recruiting nowThis study is testing a new injectable medicine called APAC, which is designed to prevent dangerous blood clots. It aims to see if APAC is safe and to find the best dose for people with severely blocked arteries in their legs, a condition that can lead to amputation. The study wi…
Matched conditions: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Phase: PHASE2 • Sponsor: Aplagon Oy • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC